Toward Setting Minimum and Optimal Data to Report for Malaria Molecular Surveillance with Targeted Sequencing: The “What” and “Why”
Jonathan J. Juliano(University of North Carolina at Chapel Hill), Jeffrey A. Bailey(Brown University), Melissa D. Conrad(University of California, San Francisco), Sean V. Connelly(University of North Carolina at Chapel Hill), Oliver J. Watson(Imperial College London), Gina Cuomo-Dannenburg, Jonathan B. Parr(University of North Carolina at Chapel Hill), Lucy Okell(Imperial College London), Christopher M. Hennelly(University of North Carolina at Chapel Hill), Isabela Gerdes Gyuricza(University of North Carolina at Chapel Hill), Kelly Carey-Ewend(University of North Carolina at Chapel Hill), George A. Tollefson(Brown University), Robert Verity(Medical Research Council), Shazia Ruybal‐Pesántez(Imperial College London), Abebe A. Fola(John Brown University), Cecile P. G. Meier-Scherling, Ashenafi Assefa(University of North Carolina at Chapel Hill), Jacob M. Sadler(University of North Carolina at Chapel Hill), Jacob Marglous(Brown University), Karamoko Niaré(The Stables), Ronald Futila Kyong-Shin, Neeva Wernsman Young(Brown University)
Cited by 1
Related Papers
A Worldwide Map of<i>Plasmodium falciparum</i>K13-Propeller Polymorphisms
|New England Journal of Medicine|2016|574
Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study
|The Lancet Infectious Diseases|2021|231
Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
|Nature Microbiology|2023|190
Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes
|The Journal of Infectious Diseases|2018|147
Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance
|The Lancet Infectious Diseases|2024|99